Rchr
J-GLOBAL ID:200901081051618830   Update date: Apr. 07, 2021

Matsuda Yasunobu

マツダ ヤスノブ | Matsuda Yasunobu
Affiliation and department:
Job title: Associate Professor
Research field  (1): Gastroenterology
Research keywords  (2): oncology ,  gastroenterologym
Research theme for competitive and other funds  (17):
  • 2010 - 現在 肝がんにおける分子標的薬耐性機構の解析
  • 1999 - 現在 肝がんにおける細胞周期調節機構の解析
  • 1990 - 現在 肝細胞増殖因子 (hepatocyte growth factor)による肝再生機構
  • 2012 - 2015 サイトカイン干渉シグナルに着目したチロシンキナーゼ阻害薬併用療法の開発
  • 2010 - 2013 DNA障害の修復機構をマーカーとした新しいインターフェロン治療の開発
Show all
Papers (110):
  • Kobayashi T, Kubota M, Kinoshita Y, Arai Y, Oyama T, Yokota N, Saito K, Matsuda Y, Osawa M. Epidermal growth factor receptor/heme oxygenase-1 axis is involved in chemoresistance to cisplatin and pirarubicin in HepG2 cell lines and hepatoblastoma specimens. Pediatric surgery international. 2019
  • Hiroki Honda, Masaaki Takamura, Satoshi Yamagiwa, Takuya Genda, Ryoko Horigome, Naruhiro Kimura, Toru Setsu, Kentaro Tominaga, Hiroteru Kamimura, Yasunobu Matsuda, et al. Overexpression of a disintegrin and metalloproteinase 21 is associated with motility, metastasis, and poor prognosis in hepatocellular carcinoma. SCIENTIFIC REPORTS. 2017. 7. 1. 15485
  • Hitoshi Kameyama, Yuki Hirose, Yasunobu Matsuda, Masayuki Nagahashi, Hiroshi Ichikawa, You Sato, Saki Yamada, Shinnosuke Hotta, Yosuke Tajima, Takuma Okamura, et al. Clinical significance of NQO1 expression in KRAS wild-type colorectal cancer. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY. 2017. 10. 5. 5841-5849
  • Masaaki Takamura, Hiroki Honda, Satoshi Yamagiwa, Naruhiro Kimura, Toru Setsu, Kentaro Tominaga, Hiroteru Kamimura, Takuya Genda, Yasunobu Matsuda, Toshifumi Wakai, et al. Biological significance of a disintegrin and metalloproteinase 21 expression in hepatocellular carcinoma. HEPATOLOGY. 2016. 64. 639A-639A
  • Masayuki Nagahashi, Yasunobu Matsuda, Kazuki Moro, Junko Tsuchida, Daiki Soma, Yuki Hirose, Takashi Kobayashi, Shin-ichi Kosugi, Kazuaki Takabe, Masaaki Komatsu, et al. DNA damage response and sphingolipid signaling in liver diseases. SURGERY TODAY. 2016. 46. 9. 995-1005
more...
MISC (197):
Books (5):
  • Sorafenib
    “Encyclopedia of Cancer” Springer Publishing 2014
  • p27
    “Encyclopedia of Cancer” Springer Publishing 2014
  • Sorafenib-Inhibited Signaling: Emerging Evidence of RAF Independent Pathways as Potential Therapeutic Targets in Hepatocellular Carcinoma.
    InTech publisher 2013 ISBN:9789535112020
  • Molecular Mechanism of DNA Damage Response Pathway During Hepatic Carcinogenesis.
    InTech publisher 2012 ISBN:9789535100232
  • Hepatocellular carcinoma - etiology, risk factors and prevention
    “Encyclopedia of Cancer” Springer Publishing 2012
Education (1):
  • 1982 - 1998 Niigata University School of Medicine
Professional career (1):
  • 医学博士 (新潟大学)
Work history (7):
  • 2007/10/01 - 現在 Niigata University Graduate School of Health Sciences Health Sciences Associate Professor
  • 2007/10/01 - 現在 Niigata University Graduate School of Health Sciences Health Sciences Associate Professor
  • 2007/10/01 - 現在 Niigata University Faculty of Medicine School of Health Sciences Associate Professor
  • 2007/04/01 - 2007/09/30 Niigata University University Medical and Dental Hospital Assistant Professor
  • 2003/10/01 - 2007/03/31 Niigata University University Medical and Dental Hospital Assistant
Show all
Awards (5):
  • 2013/10 - 欧州消化器病学会 travel grant award
  • 2011/10 - 日本臨床分子形態学会 奨励賞
  • 2006/10 - 新潟県医師会 学術奨励賞
  • 2002/06 - 新潟大学医学部消化器内科学 市田賞
  • 1996/06 - 日本生化学会 JB論文賞
Association Membership(s) (5):
日本消化管学会 ,  日本癌学会 ,  日本肝臓学会 ,  日本内科学会 ,  日本消化器内視鏡学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page